Free Access
Med Sci (Paris)
Volume 26, Number 3, Mars 2010
Page(s) 291 - 296
Section M/S revues
Published online 15 March 2010
  1. Williams SA, Greene WC. Regulation of HIV-1 latency by T-cell activation. Cytokine 2007; 39 : 63–74. [Google Scholar]
  2. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell 2002; 108 : 475–87. [Google Scholar]
  3. Treand C, Du Chêne I, Bres V, et al. Requirement for SWI/SNF chromatin-remodeling complex in Tatmediated activation of the HIV-1 promoter. EMBO J 2006; 25 : 1690–9. [Google Scholar]
  4. Ganesh L, Burstein E, Guha-Niyogi A, et al. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature 2003; 426 : 853–7. [Google Scholar]
  5. Yeung ML, Benkirane M, Jeang KT. Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions ? Retrovirology 2007; 4 : 74. [Google Scholar]
  6. Triboulet R, Benkirane M. Implication de la voie des microARN dans la réplication du VIH. Med Sci (Paris) 2007; 23 : 590–2. [Google Scholar]
  7. Triboulet R, Mari B, Lin YL, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007; 315 : 1579–82. [Google Scholar]
  8. Chun TW, Justement JS, Lempicki RA, et al. Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proc Natl Acad Sci USA 2003; 100 : 1908–13. [Google Scholar]
  9. Corbeau P. Interfering RNA and HIV: reciprocal interferences. PLoS Pathog 2008; 4 : e1000162. [Google Scholar]
  10. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387 : 188–91. [Google Scholar]
  11. Dornadula G, Zhang H, VanUitert B, et al. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. Jama 1999; 282 : 1627–32. [Google Scholar]
  12. Maldarelli F, Palmer S, King MS, et al. ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog 2007; 3 : e46. [Google Scholar]
  13. Palmer S, Wiegand AP, Maldarelli F, et al. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 2003; 41 : 4531–6. [Google Scholar]
  14. Shen L, Siliciano RF. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol 2008; 122 : 22–8. [Google Scholar]
  15. Bailey JR, Sedaghat AR, Kieffer T, et al. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol 2006; 80 : 6441–57. [Google Scholar]
  16. Llewellyn N, Zioni R, Zhu H, et al. Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy. J Leukoc Biol 2006; 80 : 1118–26. [Google Scholar]
  17. Cumont MC, Monceaux V, Viollet L, et al. TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ 2007; 14 : 1747–58. [Google Scholar]
  18. Aquaro S, Calio R, Balzarini J, et al. Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir. Antiviral Res 2002; 55 : 209–25. [Google Scholar]
  19. Stevens M, De Clercq E, Balzarini J. The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention. Med Res Rev 2006; 26 : 595–625. [Google Scholar]
  20. Rohr O, Marban C, Aunis D, Schaeffer E. Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. J Leukoc Biol 2003; 74 : 736–49. [Google Scholar]
  21. Darbinian-Sarkissian N, Darbinyan A, Otte J, et al. p27(SJ), a novel protein in St John’s Wort, that suppresses expression of HIV-1 genome. Gene Ther 2006; 13 : 288–95. [Google Scholar]
  22. Berna A, Bernier F, Chabriere E, Perera T, Scott K. DING proteins; novel members of a prokaryotic phosphate-binding protein superfamily which extends into the eukaryotic kingdom. Int J Biochem Cell Biol 2008; 40 : 170–5. [Google Scholar]
  23. Mok HP, Lever A. Waking Up the Sleepers: HIV Latency and Reactivation. J Formos Med Assoc 2008; 107 : 909–14. [Google Scholar]
  24. Geeraert L, Kraus G, Pomerantz RJ. Hide-and-seek: the challenge of viral persistence in HIV-1 infection. Annu Rev Med 2008; 59 : 487–501. [Google Scholar]
  25. Wang FX, Xu Y, Sullivan J, et al. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J Clin Invest 2005; 115 : 128–37. [Google Scholar]
  26. Chun TW, Engel D, Mizell SB, Ehler LA, Fauci AS. Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med 1998; 188 : 83–91. [Google Scholar]
  27. Mai A. The therapeutic uses of chromatin-modifying agents. Expert Opin Ther Targets 2007; 11 : 835–51. [Google Scholar]
  28. Siliciano JD, Lai J, Callender M, et al. Stability of the latent reservoir for HIV-1 in patients receiving valproic acid. J Infect Dis 2007; 195 : 833–6. [Google Scholar]
  29. Contreras X, Barboric M, Lenasi T, Peterlin BM. HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription. PLoS Pathog 2007; 3 : 1459–69. [Google Scholar]
  30. Martinez V, Autran B. Les HIV controllers : une nouvelle entité évolutive de l’infection par le VIH ? Med Sci (Paris) 2008; 24 : 7–9. [Google Scholar]
  31. Schwartz C, Le Douce V, Cherrier T, et al. Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. Partie I : la physiologie de la latence du VIH-1. Med Sci (Paris) 2010; 26 : 159–63. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.